Robotic surgery has been progressively used for gastrointestinal disease sites, mainly for cancers of the rectum, stomach, pancreas and esophagus. Gastrointestinal surgery is a cure for diseases of the parts of the body concerned in digestion. This contains the esophagus, small intestine, large intestine, stomach, and rectum. It also includes the gallbladder, liver and pancreas. Pancreas surgery is defined as pancreaticoduodenectomy, total pancreatectomy, and distal pancreatic resection. The surgery eliminates the cancerous or noncancerous expansion or damaged part of the body, for instance the intestine. It may also be used in fixing a problem such as hernia (a hole or weak mark in the wall of the abdomen). In addition, small surgical procedures are for screening & diagnosing problems of the digestive system. The rapid dispersion of new technologies in surgery, together with high potential of both patients and the mass media, has led to numerous gastrointestinal procedures being advanced by the robots.
According to study, “Global Robotic Gastrointestinal Surgery Market 2016-2025: Market Size, Share, Forecast and Strategy” some of the major companies that are currently operating in the global robotic gastrointestinal surgery market are AVRA Surgical Robotics, Inc., Medtronic Inc., Intuitive Surgical, Simbionix USA Corp., NovaTract Surgical, Inc., TransEnterix, Inc., Titan Medical.
Based on the product & services, global robotic gastrointestinal surgery market is segmented into instrument & accessories, robotic systems and system services. Based on procedure, market is segmented into rectopexy (for pelvic or rectal organ prolapsed), Barrett’s esophagus, achalasia, swallowing disorders, hernia repair, inflammatory bowel disorders, fecal incontinence, Gastroesophageal Reflux Disease (GERD), pancreatobiliary disorders, diverticulosis & diverticulitis, gastroparesis, functional bowel disorders, celiac disease, gastrointestinal bleeding, colectomy (removal of large intestine mainly due to cancer), colon polyps, gastrectomy (removal of all or part of stomach) and lower anterior resection etc. Based on equipment type, market is segmented into navigation systems, robot machines, planners & simulators and other equipments. Based on performed operations market is segmented into nissen fundoplication, cholecystectomy and heller myotomy etc.
Some of the major benefits associated are less blood loss, less pain, shorter hospital stay, faster recovery, lower risk of unwanted side effects, quicker return to daily activities and smaller scars etc. Some of the other major drawbacks include accurate lymphadenectomy, anastomotic reconstructions, and vascular sutures.
The global robotic gastrointestinal surgery is driven by increasing population, followed by increasing disposable income, growing innovative technologies and rising illness. Apart from advantages, some of the major limitations are high costs of robotic surgery contrast to laparoscopic & traditional surgery, followed by the rising learning curve and longer operation times like organizational & setup troubles etc.
Technological advancement of the robotic surgery is expected continue due to smarter and efficient assistive tools & the devices meeting the requirements of gastrointestinal surgery procedures across the world. The current open gastrointestinal surgeries and the procedures which can be replaced principally by robotic minimally include invasive surgery (RMIS). It is estimated that the more gastrointestinal surgery procedures to be commenced with at least some considerable features of the surgical robotics due to fast adoption of the advanced RMIS technology in clinical centers and hospitals. It is also expected that the global robotic gastrointestinal surgery market to reach at US $1.4 billion, by 2025.
To know more, click on the link below:-
Ankur Gupta, Head Marketing & Communications